Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.
about
Protection and pathology during parasite infection: IL-10 strikes the balanceDrug-induced exposure of Schistosoma mansoni antigens SmCD59a and SmKK7Immunoprotection of mice against Schistosomiasis mansoni using solubilized membrane antigensComparative study of transcriptome profiles of mechanical- and skin-transformed Schistosoma mansoni schistosomulaPurinergic signaling in schistosomal infectionTranscriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytesEnzymatic shaving of the tegument surface of live schistosomes for proteomic analysis: a rational approach to select vaccine candidatesSchistosoma mansoni-mediated suppression of allergic airway inflammation requires patency and Foxp3+ Treg cellsSerological screening of the Schistosoma mansoni adult worm proteomeNew insights into the reaction of Schistosoma mansoni cercaria to the human complement system.Hepatic and intestinal schistosomiasis: review.Human schistosomiasis: clinical perspective: review.Local immune responses of the Chinese water buffalo, Bubalus bubalis, against Schistosoma japonicum larvae: crucial insights for vaccine design.Kicking in the Guts: Schistosoma mansoni Digestive Tract Proteins are Potential Candidates for Vaccine DevelopmentOn the three-finger protein domain fold and CD59-like proteins in Schistosoma mansoni.Known Allergen Structures Predict Schistosoma mansoni IgE-Binding Antigens in Human Infection.The Schistosome Esophagus Is a 'Hotspot' for Microexon and Lysosomal Hydrolase Gene Expression: Implications for Blood ProcessingA vaccine consisting of Schistosoma mansoni cathepsin B formulated in Montanide ISA 720 VG induces high level protection against murine schistosomiasisSchistosoma mansoni Larvae Do Not Expand or Activate Foxp3+ Regulatory T Cells during Their Migratory Phase.Specific anti-glycan antibodies are sustained during and after parasite clearance in Schistosoma japonicum-infected rhesus macaques.Glycoconjugates in host-helminth interactionsNovel immunomic technologies for schistosome vaccine development.Proteomics at the schistosome-mammalian host interface: any prospects for diagnostics or vaccines?Specific humoral response of hosts with variable schistosomiasis susceptibility.Recent advances in proteomic applications for schistosomiasis research: potential clinical impact.SjCRT, a recombinant Schistosoma japonicum calreticulin, induces maturation of dendritic cells and a Th1-polarized immune response in mice.Cross-species prophylactic efficacy of Sm-p80-based vaccine and intracellular localization of Sm-p80/Sm-p80 ortholog proteins during development in Schistosoma mansoni, Schistosoma japonicum, and Schistosoma haematobium.Medical relevance of UK-funded non-human primate research published from January 1997 to July 2012.Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
P2860
Q27005837-2718D775-F8C8-42D3-AD1B-1880F065622EQ27304597-5511FB14-EE1B-498E-877D-A992E988C736Q27305172-39387243-36A7-4E0F-8819-7641B3D7ECCDQ27305249-AC6BA238-F188-426B-9560-DFD713248645Q28073072-F60AA950-3E3A-42BE-8564-B3C3FB6E7C4CQ28472811-00CD3A86-6AD8-4977-9618-8692DCFF59E7Q28477550-E4796C5D-48B9-43C6-9B4E-3F831CEDC90EQ28535359-2A46BFC9-901E-4867-BFC9-BFB66BED530AQ28541191-DC0B8DC6-06EE-4F27-8650-44C92B99185DQ34250377-FA9CF131-B08A-4233-B052-7FBF1988E529Q34951691-8B9B76FA-3DE0-4979-8C71-CBD1E6223ABEQ34951716-F51C5B8F-DD15-415B-897C-136035746887Q35006539-0377E990-7718-4ED0-A08F-D0E86238A7BBQ35022286-32117925-195F-412E-9394-245EE2DC9BF2Q35037028-BC14AE67-4957-46F2-BCCC-A02072A59F7CQ35042430-EDAD46B2-94B4-4F70-B2B2-EE37DEC93C85Q35862448-0F23C457-4BDD-4662-AE14-7BF8447AAFAEQ35946661-7BF2385F-7767-417E-98A1-6330CF228428Q36053541-1066D155-C100-4528-84DA-548BE9938211Q36267300-27CC32CC-53C0-4E81-A958-8AAB6A3B9EC9Q37126736-CA501663-635B-4EC2-A804-24C40D8D7298Q38001044-7830D1D9-24D0-46FF-97E7-05456772BBFFQ38020270-F0C0AD38-F5E5-4044-A84F-9FB74EB0C54DQ38978103-5E5793B4-3685-4A19-B0CC-B16FEFD06C2FQ39034549-63BC4098-FFBA-4856-AD0E-D244057DCDA5Q44497423-98969775-6260-4E4E-81FC-95A4E5149EE3Q46287356-B760EAAA-CAEA-4B8F-B73F-34F5BB6B7FF2Q55031158-FD1FD944-D2CE-4920-91BB-E1A2EC1772A3Q55112826-5C46889F-E91F-4CA7-A4B9-23784EC899AA
P2860
Immune effector mechanisms against schistosomiasis: looking for a chink in the parasite's armour.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Immune effector mechanisms aga ...... hink in the parasite's armour.
@ast
Immune effector mechanisms aga ...... hink in the parasite's armour.
@en
type
label
Immune effector mechanisms aga ...... hink in the parasite's armour.
@ast
Immune effector mechanisms aga ...... hink in the parasite's armour.
@en
prefLabel
Immune effector mechanisms aga ...... hink in the parasite's armour.
@ast
Immune effector mechanisms aga ...... hink in the parasite's armour.
@en
P2860
P356
P1476
Immune effector mechanisms aga ...... hink in the parasite's armour.
@en
P2093
Patricia S Coulson
R Alan Wilson
P2860
P304
P356
10.1016/J.PT.2009.05.011
P577
2009-08-28T00:00:00Z